University of Wisconsin In vivo Cellular and Molecular Imaging Center (WICMIC)

The University of Wisconsin In vivo Cellular and Molecular Imaging Center (WICMIC) was established to lead, coordinate, and facilitate multi-disciplinary research focused on discovering, developing and translating molecular imaging technologies into clinical practice. WICMIC is focused on developing molecular imaging strategies as tools for guiding personalized treatment decisions. We aim to achieve this by exploring the uniqueness of molecular imaging to:

(1) Explain the biological basis that leads to variable treatment response

(2) Improve clinical outcomes by selecting appropriate treatments

The WICMIC efforts will be seamlessly integrated with the existing translational research efforts within the UW Carbone Cancer Center (UWCCC) and its resources. We have developed a strategic plan for increased integration of physical, biological, chemical, biochemical, pharmacological and engineering resources across the UW campus with a molecular imaging focus. This integration is summarized with the creation of a specialized Molecular Imaging Technology and Agent Development (MITAD) resource that provides a “pathway” resource for fast and efficient development of molecular imaging agents from its discovery to clinical use, as well as Molecular Imaging Agent Production (MIAP) and Molecular Imaging Informatics (MIINF) resources, which provide the necessary molecular imaging agents and informatics infrastructure to support the WICMIC projects. We have developed a strategic plan for increased engagement of scientists from disciplines that are traditionally not involved in molecular imaging by creating a Molecular Imaging Career Development (MICAD) program, comprising of multi-disciplinary training and supervision.